April 03, 2026 01:00 ET | Source: Ipsen Pharma PARIS, FRANCE, 3 April 2026 — Ipsen (Euronext: IPN; ADR: IPSEY) announces…
Ipsen announces the availability of its 2025 Universal Registration Document PARIS, FRANCE, 1 APRIL 2026 - Ipsen (Euronext: IPN; ADR:…
Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article…
14 abstracts will be presented across a range of neurological conditions including post‑stroke spasticity, cervical dystonia, blepharospasm and other movement…
Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8…
PARIS, FRANCE, 5 December 2025, Ipsen (Euronext: IPN; ADR: IPSEY) has been informed that the shares of Beech Tree will be…
Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article…
Aggregated presentation by day and by marketStatement of transactions in own shares from 1st September to 5th September 2025 Name of…
Aggregated presentation by day and by marketStatement of transactions in own shares from August 11th to August 15th 2025 Name of…
H1 total sales growth of 11.4% at CER1, or 9.7% as reported, driven by the three therapeutic areas: 95.7% in…